Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
87.97
+0.81 (0.93%)
At close: Jun 18, 2026, 4:00 PM EDT
89.90
+1.93 (2.19%)
After-hours: Jun 18, 2026, 7:30 PM EDT

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 26 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Hold" and an average price target of $98.7. The average 1-year stock price forecast is 12.20% higher than the current stock price, while the lowest is $83 (-5.65%) and the highest is $130 (+47.78%).

Price Target: $98.7 (+12.20%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$83$98.7$94$130
Change-5.65%+12.20%+6.85%+47.78%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy766666
Buy232222
Hold161717171717
Sell111100
Strong Sell221111
Total282927272626

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Hold
Reiterates
$100
HoldReiterates$100+13.68%Jun 12, 2026
Wells Fargo
Wells Fargo
Hold
Reiterates
$90
HoldReiterates$90+2.31%Jun 2, 2026
Citi
Citi
Hold
Maintains
$95$93
HoldMaintains$95$93+5.72%May 28, 2026
William Blair
William Blair
Hold
Maintains
n/a
HoldMaintainsn/an/aApr 29, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$100$95
HoldMaintains$100$95+7.99%Apr 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
8.54B
from 8.23B
Increased by 3.79%
Revenue Next Year
8.84B
from 8.54B
Increased by 3.43%
EPS This Year
8.48
from 8.20
Increased by 3.39%
EPS Next Year
8.99
from 8.48
Increased by 6.04%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.83B6.94B7.39B7.68B8.23B8.54B
Revenue Growth
11.42%1.65%6.55%3.85%7.20%3.79%
Gross Profit
4.87B4.92B5.32B5.50B5.74B6.07B
Gross Margin
71.29%70.90%71.93%71.61%69.71%71.04%
Operating Income
1.22B1.29B1.51B1.59B1.40B2.31B
Net Income
401.60M231.40M1.02B903.80M705.10M925.34M
EPS
----8.208.48
EPS Growth
----2.50%3.39%
Forward PE
16.4018.6315.4712.5210.7210.38
Dividend / Share
0.960.960.960.960.961.03
Dividend Growth
-----7.20%
Free Cash Flow
891.55M1.65B1.13B1.06B1.35B1.29B
No. Analysts
-----25
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High8.6B
Avg8.5B
Low8.4B

Revenue Growth

Revenue Growth202620272028
High
4.4%
Avg
3.8%
Low
2.3%

EPS Forecast

EPS202620272028
High8.53
Avg8.48
Low8.35

EPS Growth

EPS Growth202620272028
High
4.0%
Avg
3.4%
Low
1.8%